GO:0019784 deNEDDylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019784 deNEDDylase activity is an isopeptidase activity that removes the ubiquitin-like protein NEDD8 from conjugated target proteins.
• The best-characterized deNEDDylases are the COP9 signalosome (CSN) and NEDP1/DEN1, which regulate cullin-RING ligases (CRLs) and many other substrates [1,3,4].
• Deneddylation controls protein stability, localization, and activity, and is essential for diverse processes including cell cycle progression, DNA replication, and immune responses [3,7].
• Dysregulated deNEDDylase activity is implicated in cancer, viral replication, and metabolic disorders, making it a potential therapeutic target [2,3,8].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect deNEDDylase function in health and disease [1,6].
• Studying deNEDDylase activity requires integrating biochemical assays, proteomics, and functional genomics to link molecular events to cellular phenotypes [4,5].
Description
GO:0019784 deNEDDylase activity is a molecular function defined as an isopeptidase activity that cleaves NEDD8 from a target protein to which it is conjugated. NEDD8 is a ubiquitin-like modifier that is covalently attached to lysine residues on substrate proteins, a process termed neddylation. Deneddylation, the reversal of this modification, is catalyzed by specialized proteases that recognize the NEDD8 moiety and hydrolyze the isopeptide bond. This activity is critical for maintaining the dynamic equilibrium of protein neddylation and for regulating the function of numerous cellular proteins [1,4]. The most extensively studied deNEDDylase is the COP9 signalosome (CSN), an evolutionarily conserved multiprotein complex that removes NEDD8 from cullin-RING ligases (CRLs) [1,4]. Another key enzyme is NEDP1 (also known as DEN1), a cysteine protease that processes NEDD8 precursors and deconjugates NEDD8 from target proteins. In addition, certain viruses encode deNEDDylases, such as the Epstein-Barr virus (EBV) protein BPLF1, which modulates host CRL activity to promote viral replication. The importance of deNEDDylase activity extends to cancer, where aberrant neddylation and deneddylation contribute to tumor development and progression. Researchers study deNEDDylase activity to understand how post-translational modifications control protein stability, localization, and interactions. The dynamic interplay between neddylation and deneddylation influences cell cycle progression, DNA damage responses, immune signaling, and metabolism [7,8]. This article provides a comprehensive overview of the molecular mechanism, key genes, regulatory networks, disease relevance, and research methodologies associated with GO:0019784 deNEDDylase activity.
deNEDDylase activity At A Glance
| GO ID | GO:0019784 |
|---|---|
| GO term | deNEDDylase activity |
| Ontology | molecular_function |
| Synonym | NEDD8-specific protease activity |
| Definition | An isopeptidase activity that cleaves NEDD8 from a target protein to which it is conjugated. |
| Major function | Removal of NEDD8 from conjugated proteins, regulating cullin-RING ligases and other substrates. |
| Key enzymes | COP9 signalosome (CSN), NEDP1/DEN1, viral deNEDDylases (e.g., EBV BPLF1). |
| Substrates | Cullins, PTEN, and other neddylated proteins. |
| Disease relevance | Cancer, viral infections, metabolic disorders, immune regulation. |
What Is GO:0019784?
deNEDDylase activity (GO:0019784) is an enzymatic activity that removes the ubiquitin-like protein NEDD8 from a target protein to which it is covalently attached. It is classified as an isopeptidase because it hydrolyzes the isopeptide bond between the C-terminal glycine of NEDD8 and a lysine residue on the substrate. This activity is synonymous with NEDD8-specific protease activity and is essential for reversing neddylation, thereby regulating protein function and stability.
Why Is deNEDDylase activity Important in Cell Biology?
deNEDDylase activity is crucial for cellular homeostasis because it counteracts neddylation, a post-translational modification that controls the activity of cullin-RING ligases (CRLs) and many other proteins [1,4]. By removing NEDD8, deNEDDylases such as the COP9 signalosome regulate the assembly and function of CRLs, which in turn control the degradation of key regulatory proteins involved in cell cycle, DNA repair, and signal transduction. Dysregulation of deNEDDylase activity has been linked to cancer, where altered neddylation of PTEN affects its nuclear import and tumor-suppressive functions. Furthermore, viral deNEDDylases, such as the Epstein-Barr virus BPLF1 protein, manipulate host CRL activity to promote viral DNA replication, highlighting the importance of this activity in host-pathogen interactions. Understanding deNEDDylase activity is therefore essential for deciphering fundamental cellular processes and for developing therapeutic strategies targeting neddylation pathways.
• Regulates cullin-RING ligase (CRL) activity by removing NEDD8 from cullins, thereby controlling protein degradation.
• Modulates the stability and function of non-cullin substrates such as PTEN, affecting tumor development.
• Essential for cell cycle progression and DNA replication, as shown by studies on viral deNEDDylases.
• Influences immune responses, including CD8+ T-cell metabolism and antitumor immunity.
• Implicated in metabolic diseases, where neddylation and deneddylation balance is disrupted.
• Plays a role in fungal development and stress responses, as demonstrated in Aspergillus nidulans.
• Targeted by viral proteins to create a favorable environment for replication.
• Provides a potential therapeutic target for cancers with aberrant neddylation pathways.
• Serves as a model for studying enzyme complex regulation, as seen with the COP9 signalosome.
• Enables precise control of protein function through reversible post-translational modification.
What Happens During deNEDDylase activity?
Recognition of NEDD8-Modified Substrates
In simple terms: The enzyme first finds and binds to proteins that have NEDD8 attached.
deNEDDylases specifically recognize NEDD8-conjugated substrates through interactions with both the NEDD8 moiety and the target protein. The COP9 signalosome (CSN) binds to cullin-RING ligases (CRLs) via its CSN1 and CSN2 subunits, positioning the catalytic CSN5 subunit near the NEDD8-cullin isopeptide bond [1,4]. NEDP1/DEN1 recognizes NEDD8 through a conserved catalytic cleft that accommodates the ubiquitin-like fold. This substrate recognition is highly specific, ensuring that only NEDD8, and not ubiquitin or other ubiquitin-like proteins, is removed.
Cleavage of the Isopeptide Bond
In simple terms: The enzyme cuts the chemical bond that holds NEDD8 to the target protein.
Once bound, the deNEDDylase catalyzes the hydrolysis of the isopeptide bond between the C-terminal glycine of NEDD8 and a lysine residue on the substrate. This reaction is mediated by a catalytic cysteine residue in the active site, which performs a nucleophilic attack on the carbonyl carbon of the isopeptide bond, forming an acyl-enzyme intermediate that is subsequently hydrolyzed. The COP9 signalosome utilizes its CSN5 subunit, a metalloprotease-like enzyme, to cleave NEDD8 from cullins [1,5]. The reaction releases free NEDD8 and the unmodified target protein, allowing the substrate to regain its original conformation and function.
Release of Deneddylated Substrate and NEDD8
In simple terms: After cutting, the enzyme lets go of both the protein and the removed NEDD8.
Following cleavage, the deneddylated substrate and free NEDD8 are released from the enzyme. The substrate can then participate in downstream cellular processes, such as CRL disassembly or altered protein-protein interactions. Free NEDD8 can be recycled for another round of conjugation by the neddylation machinery. The release step is crucial for catalytic turnover and is regulated by conformational changes in the deNEDDylase complex. In the case of the COP9 signalosome, deneddylation of cullins leads to the dissociation of the CRL complex and the subsequent binding of the inhibitor CAND1, which prevents premature re-neddylation.
Regulation of deNEDDylase Activity
In simple terms: The enzyme's activity is turned on or off by other molecules and modifications.
deNEDDylase activity is tightly regulated to maintain cellular homeostasis. The COP9 signalosome is activated by simultaneous neddylation of its CSN5 subunit, which enhances its deneddylase activity. In fungi, integration of the catalytic subunit Csn5 into the CSN complex is required for in vivo deneddylase activity, representing a final step in complex assembly. Additionally, the activity of NEDP1 can be modulated by post-translational modifications and interacting proteins. Viral deNEDDylases, such as EBV BPLF1, are expressed at specific stages of the viral life cycle to manipulate host CRL activity. These regulatory mechanisms ensure that deneddylation occurs at the right time and place to control substrate fate [1,4].
Key Genes Involved in GO:0019784 deNEDDylase activity
The following genes and proteins are central to deNEDDylase activity, either as catalytic enzymes, regulatory subunits, or substrates.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CSN5 (COPS5) | Catalytic subunit of the COP9 signalosome; cleaves NEDD8 from cullins | Key enzyme for CRL regulation; knockout studies reveal essential roles in development and cancer [1,4] |
| CSN1 (COPS1) | Scaffold subunit of the COP9 signalosome; binds CRLs | Required for substrate recognition; mutations affect CSN assembly and function |
| CSN2 (COPS2) | Subunit of the COP9 signalosome; involved in CRL binding | Modulates deneddylase specificity; knockout leads to CRL dysregulation |
| NEDP1 (DEN1, SENP8) | Cysteine protease that deconjugates NEDD8 from substrates | Processes NEDD8 precursors and regulates non-cullin substrates; implicated in cancer |
| CUL1 | Cullin-RING ligase scaffold; major substrate of deNEDDylases | Deneddylation controls CRL assembly and substrate degradation |
| CUL2 | Cullin-RING ligase scaffold; deneddylated by CSN | Regulates CRL2 activity; important in hypoxia signaling |
| CUL3 | Cullin-RING ligase scaffold; deneddylated by CSN | Mutations in CUL3 linked to hypertension and developmental disorders |
| CUL4A | Cullin-RING ligase scaffold; deneddylated by CSN | Involved in DNA damage response; deneddylation affects CRL4 function |
| CUL4B | Cullin-RING ligase scaffold; deneddylated by CSN | X-linked intellectual disability associated with CUL4B mutations |
| CUL5 | Cullin-RING ligase scaffold; deneddylated by CSN | Regulates CRL5 activity in immune signaling |
| PTEN | Tumor suppressor; neddylated and deneddylated | Neddylation of PTEN regulates nuclear import and tumor development |
| BPLF1 | Epstein-Barr virus deNEDDylase | Promotes viral DNA replication by regulating CRL activity |
| CSN3 (COPS3) | Subunit of the COP9 signalosome | Required for complex stability and deneddylase activity |
| CSN4 (COPS4) | Subunit of the COP9 signalosome | Involved in CRL binding and deneddylation |
| CSN6 (COPS6) | Subunit of the COP9 signalosome | Regulates CSN complex integrity and activity |
| CSN7 (COPS7) | Subunit of the COP9 signalosome | Essential for CSN assembly and function |
| CSN8 (COPS8) | Subunit of the COP9 signalosome | Modulates CSN activity and substrate specificity |
| UBE2M (UBC12) | NEDD8-conjugating enzyme | Works in opposition to deNEDDylases to regulate neddylation balance |
How Is deNEDDylase activity Regulated?
deNEDDylase activity is regulated at multiple levels. The COP9 signalosome is activated by neddylation of its CSN5 subunit, which enhances its deneddylase activity. In fungi, the integration of Csn5 into the CSN complex is a prerequisite for in vivo deneddylase activity, serving as a final step in complex assembly. Additionally, the activity of NEDP1 can be modulated by post-translational modifications and interacting proteins. Viral deNEDDylases, such as EBV BPLF1, are expressed at specific stages of the viral life cycle to manipulate host CRL activity. These regulatory mechanisms ensure that deneddylation occurs at the right time and place to control substrate fate [1,4].
deNEDDylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTEN | Cancer (tumor development, nuclear import) | Knock-in of neddylation-deficient PTEN mutant; overexpression of deNEDDylase |
| CSN5 (COPS5) | Cancer (overexpression in tumors) | CRISPR knockout of CSN5 in cancer cell lines; point mutation of catalytic cysteine [1,4] |
| BPLF1 | Epstein-Barr virus infection (viral replication) | Knockout of BPLF1 in EBV-infected cells; overexpression in reporter assays |
| CUL3 | Hypertension, developmental disorders | Knock-in of disease-associated CUL3 mutations; knockout of CSN subunits |
| NEDP1 (DEN1) | Cancer, metabolic disorders | Knockout and overexpression models to study substrate specificity [3,8] |
Cancer
Dysregulated deNEDDylase activity contributes to cancer through altered neddylation of key proteins. For example, neddylation of PTEN regulates its nuclear import and promotes tumor development, and deNEDDylases that remove NEDD8 from PTEN can influence its subcellular localization and tumor-suppressive functions. The COP9 signalosome, a major deNEDDylase, is often overexpressed in various cancers and correlates with poor prognosis. Its deneddylase activity controls the stability of many oncoproteins and tumor suppressors by regulating CRL-mediated degradation. Targeting deNEDDylase activity is therefore a potential therapeutic strategy in oncology.
Viral Infections
Viruses encode deNEDDylases to manipulate host cellular machinery. The Epstein-Barr virus protein BPLF1 acts as a deNEDDylase that regulates cullin-RING ligase activity, promoting viral DNA replication. By deneddylating cullins, BPLF1 alters the degradation of host proteins to create a favorable environment for viral replication. This highlights the importance of deNEDDylase activity in host-pathogen interactions and suggests that inhibiting viral deNEDDylases could be an antiviral strategy.
Metabolic Disorders
Neddylation and deneddylation are emerging as critical regulators of metabolism. Dysregulation of these processes has been linked to metabolic diseases such as obesity and diabetes. DeNEDDylases may influence metabolic pathways by controlling the stability of key metabolic enzymes and signaling proteins. Understanding how deNEDDylase activity contributes to metabolic homeostasis could lead to new therapeutic approaches for metabolic disorders.
Immune Regulation
deNEDDylase activity plays a role in immune cell function. NEDDylation regulates CD8+ T-cell metabolism and antitumor immunity, and deNEDDylases are likely involved in fine-tuning these responses. Modulating deNEDDylase activity could enhance T-cell-based immunotherapies. Further research is needed to fully elucidate the mechanisms by which deNEDDylases control immune cell fate and function.
From deNEDDylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of deNEDDylase loss on cell viability? | CRISPR knockout of CSN5 or NEDP1 in cancer cell lines [1,3] |
| How does a catalytic point mutation affect deNEDDylase activity? | Point mutation (e.g., CSN5 Cys->Ala) knock-in via CRISPR [1,5] |
| Does a disease-associated mutation alter substrate recognition? | Knock-in of patient-derived mutations in CSN subunits or NEDP1 |
| Where does deNEDDylase localize in cells? | Tagged knock-in (e.g., GFP-CSN5) for live-cell imaging |
| What happens when deNEDDylase is overexpressed? | Overexpression of CSN5 or NEDP1 using lentiviral vectors [3,8] |
| Which substrates are affected by deNEDDylase inhibition? | Proteomics and diGly enrichment in knockout or inhibitor-treated cells |
How to Study the deNEDDylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro deNEDDylase assay | Cleavage of NEDD8 from substrates | Enzyme kinetics, inhibitor screening [1,5] |
| Western blot with anti-NEDD8 | Levels of neddylated proteins | Monitoring deneddylation in cell lysates |
| Mass spectrometry (diGly) | Global neddylation sites | Identifying deNEDDylase substrates |
| CRISPR knockout screen | Genes required for deNEDDylase function | Discovering synthetic lethal interactions [1,6] |
| Fluorescence microscopy | Subcellular localization of deNEDDylases | Live-cell imaging of tagged proteins [1,3] |
| Co-immunoprecipitation | Protein-protein interactions | Identifying CSN complex components |
| RNA-seq | Transcriptional changes upon deNEDDylase loss | Pathway analysis and target identification |
| Metabolic assays | Cellular metabolism (e.g., glycolysis, OXPHOS) | Linking deNEDDylase to metabolic regulation [7,8] |
Biochemical Assays for deNEDDylase Activity
In vitro deNEDDylase assays use recombinant enzymes and NEDD8-conjugated substrates (e.g., NEDD8-cullin) to measure cleavage by fluorescence or Western blot. These assays are essential for determining kinetic parameters and inhibitor efficacy [1,5]. For the COP9 signalosome, activity can be monitored by the release of NEDD8 from cullins using gel-based or mass spectrometry-based methods.
Proteomics and Neddylation Profiling
Mass spectrometry-based proteomics can identify NEDD8-modified proteins and quantify changes upon deNEDDylase manipulation. DiGly enrichment followed by LC-MS/MS allows global profiling of neddylation sites, revealing substrates and pathways regulated by deNEDDylases. This approach is powerful for discovering novel deNEDDylase targets and understanding their dynamics.
CRISPR Screens and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes that modulate deNEDDylase activity or that are synthetically lethal with deNEDDylase loss. Such screens have been used to uncover pathways that depend on CSN5 or NEDP1 [1,6]. Combining CRISPR screens with small-molecule inhibitors of neddylation can reveal resistance mechanisms and potential drug targets.
Imaging and Subcellular Localization
Fluorescence microscopy of tagged deNEDDylases (e.g., GFP-CSN5) enables real-time visualization of their subcellular localization and dynamics. This method can reveal how deNEDDylases are recruited to specific compartments, such as the nucleus or cytoplasm, under different conditions [1,3]. Co-localization studies with CRL components provide insights into substrate engagement.
How CRISPR Can Be Used to Study GO:0019784 deNEDDylase activity
Knockout
CRISPR knockout of deNEDDylase genes such as CSN5 or NEDP1 allows researchers to study loss-of-function phenotypes. Knockout cell lines can reveal essential roles in cell proliferation, CRL regulation, and substrate accumulation [1,3]. For example, CSN5 knockout leads to cullin deneddylation defects and altered protein stability. These models are valuable for validating drug targets and understanding disease mechanisms.
Point Mutation
Introducing point mutations in the catalytic domain of deNEDDylases (e.g., CSN5 Cys->Ala) via CRISPR knock-in enables precise dissection of enzymatic activity versus scaffolding functions. Such mutants can distinguish between deneddylase-dependent and independent roles of the COP9 signalosome [1,5]. Point mutations in substrate recognition domains can also reveal specificity determinants.
Knock-in
Knock-in of tagged deNEDDylases (e.g., GFP or HA) allows for endogenous expression and localization studies. This approach preserves native regulation and can be used for proteomic identification of interacting partners. Knock-in of disease-associated mutations (e.g., in CUL3 or CSN subunits) provides models to study pathological mechanisms.
Overexpression
Overexpression of deNEDDylases using lentiviral or inducible systems can amplify their activity and reveal gain-of-function phenotypes. This is useful for studying substrate specificity and for screening inhibitors [3,8]. Overexpression of viral deNEDDylases like BPLF1 in host cells can mimic viral infection and uncover host-pathogen interactions.
How EDITGENE Supports deNEDDylase activity Research
Researchers studying deNEDDylase activity-related genes often need to determine whether a candidate gene is causally involved in a specific cellular process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of deNEDDylase components and their substrates.
Contact EDITGENE today to design your custom CRISPR model for deNEDDylase activity research.
Frequently Asked Questions About deNEDDylase activity
What is deNEDDylase activity?
deNEDDylase activity (GO:0019784) is an isopeptidase activity that removes the ubiquitin-like protein NEDD8 from conjugated target proteins, reversing neddylation.
What genes are involved in deNEDDylase activity?
Key genes include CSN5 (COPS5), NEDP1 (DEN1/SENP8), and other COP9 signalosome subunits such as CSN1-CSN8. Viral deNEDDylases like EBV BPLF1 also exhibit this activity [1,3].
What is the function of deNEDDylase activity?
It regulates protein stability, localization, and activity by removing NEDD8, thereby controlling cullin-RING ligase assembly and substrate degradation.
How is deNEDDylase activity regulated?
It is regulated by neddylation of the CSN5 subunit, complex assembly, and post-translational modifications. Viral deNEDDylases are expressed at specific stages of infection [3,5].
What diseases are associated with deNEDDylase activity?
Dysregulation is linked to cancer, viral infections, metabolic disorders, and immune dysfunction [2,3,7,8].
What methods are used to study deNEDDylase activity?
Common methods include in vitro cleavage assays, Western blotting, mass spectrometry, CRISPR screens, and fluorescence microscopy [1,4].
Can CRISPR be used to study deNEDDylase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional dissection of deNEDDylases [1,6].
What is the COP9 signalosome?
The COP9 signalosome is a multiprotein complex with deNEDDylase activity that removes NEDD8 from cullins, regulating CRL function [1,4].
Is deNEDDylase activity a drug target?
Yes, inhibitors of deNEDDylases or the neddylation pathway are being explored for cancer therapy [2,8].
How does deNEDDylase activity affect the immune system?
It regulates CD8+ T-cell metabolism and antitumor immunity, influencing immune responses.
Conclusion
deNEDDylase activity (GO:0019784) is a fundamental enzymatic function that reverses neddylation, thereby controlling the stability and activity of numerous proteins, including cullins and PTEN. Its dysregulation is implicated in cancer, viral infections, metabolic disorders, and immune dysfunction. The COP9 signalosome and NEDP1 are the primary deNEDDylases in human cells, and their activity is tightly regulated. Advances in CRISPR-based models and proteomic technologies are accelerating our understanding of this critical modification. Targeting deNEDDylase activity holds promise for therapeutic intervention in multiple diseases.
References
- 1. Kim K et al.. 2017. Deneddylase 1 regulates deneddylase activity of the Cop9 signalosome in Drosophila melanogaster.. Insect Sci 24(1):27-34 PMID: 26332639
- 2. Xie P et al.. 2021. Neddylation of PTEN regulates its nuclear import and promotes tumor development.. Cell Res 31(3):291-311 PMID: 33299139
- 3. Gastaldello S et al.. 2010. A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases.. Nat Cell Biol 12(4):351-61 PMID: 20190741
- 4. Suisse A et al.. 2018. The COP9 signalosome inhibits Cullin-RING E3 ubiquitin ligases independently of its deneddylase activity.. Fly (Austin) 12(2):118-126 PMID: 29355077
- 5. Bornstein G et al.. 2015. COP9-Signalosome deneddylase activity is enhanced by simultaneous neddylation: insights into the regulation of an enzymatic protein complex.. Cell Div 10:5 PMID: 26265931
- 6. Beckmann EA et al.. 2015. Integration of the catalytic subunit activates deneddylase activity in vivo as final step in fungal COP9 signalosome assembly.. Mol Microbiol 97(1):110-24 PMID: 25846252
- 7. Jiménez-Lasheras B et al.. 2025. NEDDylation Regulates CD8+ T-cell Metabolism and Antitumor Immunity.. Cancer Immunol Res 13(7):1004-1021 PMID: 40261130
- 8. Ren H et al.. 2024. A novel approach to explore metabolic diseases: Neddylation.. Pharmacol Res 210:107532 PMID: 39637955
